NASDAQ · Medical - Instruments & Supplies

KRMD (KRMD) Stock

$4.11 +0.00% NASDAQ: KRMD Healthcare

Valuation

MetricValue
Price$4.11
Market Cap$188.78M
P/E Ratio-67.33
P/B Ratio10.92
P/S Ratio4.25
EPS (TTM)$-0.06
52-Week High$6.61
52-Week Low$2.91
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-17.65%
ROA-10.71%
ROCE-17.65%
Gross Margin-7.32%
Operating Margin-7.32%
Net Margin-5.27%
Debt/Equity0.20
Current Ratio2.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$23.0M$28.0M$29.0M$34.0M$41.0M
Operating Profit$-7.0M$-11.0M$-10.0M$-6.0M$-3.0M
Net Profit$-5.0M$-9.0M$-14.0M$-6.0M$-3.0M
EPS$-0.10$-0.19$-0.30$-0.13$-0.06
Op Margin-29.9%-38.6%-36.0%-19.2%-7.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$41.0M$42.0M$28.0M$27.0M$28.0M
Total Liabilities$5.0M$11.0M$8.0M$10.0M$11.0M
Cash$25.0M$17.0M$11.0M$10.0M$9.0M
Borrowings$1.0M$5.0M$4.0M$4.0M$3.0M

Latest News

KORU Medical Systems to Report Second Quarter 2026 Financial Results on August 5, 2026 Business Wire · Jul 15, 2026 May 2026 Penny Stocks Worth Watching Simply Wall St. · May 8, 2026 KORU Medical Systems, Inc. Q1 2026 Earnings Call Summary Moby · May 7, 2026 KORU Medical Systems Q1 Earnings Call Highlights MarketBeat · May 7, 2026 We Think KORU Medical Systems (NASDAQ:KRMD) Can Easily Afford To Drive Business Growth Simply Wall St. · May 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-4.0M$-5.0M$-5.0M$0$0
Investing Cash Flow$-1.0M$-6.0M$-2.0M$-3.0M$-2.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-2.0M$-8.0M$-6.0M$-2.0M$-1.0M
Free Cash Flow$-5.0M$-8.0M$-6.0M$-2.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield0.10%
Quick Ratio1.82
Interest Coverage—
Return 1Y28.88%
Return 3Y42.61%
Return 5Y25.38%

Ownership

Insiders Held8.01%
Institutions Held57.08%
Institutions Float Held62.05%
Institutional HolderSharesReport Date
First Light Asset Management, LLC3,768,3802026-03-31
Topline Capital Management, LLC3,514,9112026-03-31
Blackrock Inc.2,371,8262026-03-31
Vanguard Capital Management LLC1,686,2242026-03-31
Geode Capital Management, LLC1,051,2082026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
HIND $2.17 +0.23% -0.44 $15.23M 0.00%
INFU $9.92 +5.98% 32.90 $200.20M 0.00%
MXCT $1.18 +6.31% -2.55 $126.40M 0.00%
NYXH $1.41 -2.76% -1.23 $55.85M 0.00%
OSUR $4.05 +1.25% -3.29 $278.84M 0.00%

About KRMD

KRMD is led by CEO Linda Tharby, employs 80 people, headquartered in US, publicly traded since 1994.

KRMD stock trades at $4.11 with a market capitalization of $188.78M. The stock is valued at a price-to-earnings (P/E) ratio of -67.33, price-to-book of 10.92, price-to-sales of 4.25. Over the past 52 weeks the stock has ranged between $2.91 and $6.61, and currently trades 37.8% below its 52-week high.

On profitability, KRMD generates a return on equity (ROE) of -17.65%, return on capital employed of -17.65%, an operating margin of -7.32%, a net profit margin of -5.27%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides